Entact Bio, co-founded by Arkin Bio, is utilizing its proprietary Encompass™ platform, designing enhancement-targeting chimeric (ENTAC™) molecules that link deubiquitinases (DUBs) with dysregulated proteins.
Arkin Entry Stage
Discovery
Status
Active
Location
Boston, MA
Let’s get in touch!
